Tamoxifen Can Cause Aggressive Cancer Tumours August 29, 2009
Posted by TruthSeeker in Big Pharma, Breast Cancer.add a comment
Long-term users of cancer prevention drug Tamoxifen it is reported, could develop rare cancers from taking it, since it is the drug of choice, prescribed after the detection of breast cancer or surgery. This is disturbing news for healthgivers and breast cancer survivors, many of whom are long term users of tamoxifen, with a 20% success rate in preventing further incidences of cancer.Tamoxifen, which is the most prescribed and oldest selective estrogen receptor modulator (SERM) prescribed for women with breast cancer and rare but aggressive tumours, as it is known to block estrogen receptors in the breast, inhibiting their growth. Which is why, tamoxifen so successful in preventing a recurrence of common breast tumours, and while it has come under scrutiny of late, some suggest the risks still outweigh the downside.The journal Cancer Research reports a study of 1100-women with estrogen sensitive tumours. Women who took tamoxifen for 5-years, there was a 60% less risk of a recurrence of estrogen sensitive breast cancer. Though, they were four times more likely to develop rare and extremely aggressive breast cancer that was not estrogen sensitive, rendering Tamoxifen ineffective.The medical community, in its typical reaction to bad news, has begun to question the report and its methodology, and it is especially bad news, because tamoxifen is used as the frontline defence in the fight against cancer.The report published in Cancer Research, is not based on any research study, rather only on observation made by the esteemed Fred Hutchinson Cancer Research Centre, Seattle, WA, which has long been known for comprehensive scientific research and reporting.According to Dr. Li, the author of the report, long term tamoxifen usage increases a four-fold risk for a more aggressive, difficult-to-treat cancer type in the opposite breast or contralateral, to the initial tumour.The current report is pursuant to Dr. Li’s previously published findings in 2001, which study of 9,000-women over the age of 50 followed from 1990 and 1999, reported the same findings i. e. a five-fold increased risk of estrogen-receptor (ER)-negative breast cancers in breast cancer survivors taking tamoxifen.Tamoxifen use has been seen to reduce ER-positive contralateral breast cancers, which is the most common type of cancer, found in two-thirds of the cases diagnosed by 20%. With new findings showing a 500% increase in estrogen-receptor (ER)-negative breast cancers, breast cancer survivors and caregivers need to assess risks vs. benefits, including looking for alternative treatments.New homeopathy and botanical medicine research looks promising for both cancer prevention and cancer relapse, minus side effects triggered by tamoxifen and other drugs.
Submitted by: Anna Tomova
Breast Cancer Screening May Lead to Overdiagnosis July 22, 2009
Posted by TruthSeeker in Breast Cancer.add a comment
Researchers from Denmark have reported that one-third of women may be unnecessarily treated for breast cancer as a result of public screening programs that over-diagnose the disease. The results of this study appeared in an early online publication in the British Medical Journal on July 9, 2009.
Breast cancer is the second leading cause of cancer death in women in the United States, with approximately 180,000 cases diagnosed each year. The best “treatment” for cancer is to prevent its occurrence or to detect it early when it is most treatable. As a result, screening for breast cancer has become standard for women over 40 as well as women who are at high risk of developing the disease. Read More…
Breast cancer survival in Canada and the USA: meta-analytic evidence of a Canadian advantage in low-income areas July 22, 2009
Posted by TruthSeeker in Breast Cancer.add a comment
Conclusions More inclusive health care insurance coverage in Canada vs the USA, particularly among each country’s relatively poor people, seems the most plausible explanation for such Canadian advantages. Provision of health care for all Americans would likely prevent countless early deaths, particularly among the relatively poor.
Keywords Breast cancer, socio-economic factors, place, survival, node positive breast cancer, meta-analysis, health insurance, single payer, Canada, USA Read More…
Exposed: 10 Facts about the Breast Cancer Industry You’re Not Supposed to Know March 26, 2009
Posted by TruthSeeker in Breast Cancer, Cancer.add a comment
With Breast Cancer Awareness month fully upon us once again, retail stores have been invaded with everything pink, including “pink ribbon” candies and personal care products made with blatantly cancer-causing ingredients. Retail grocery stores like Safeway even hit up customers for donations at the cash register, promising to raise funds to find “the cure for cancer.” Read More…
